Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
Sign Up to like & getrecommendations! Published in 2017 at "Oncogene"
DOI: 10.1038/onc.2017.270
Abstract: Signal transducer and activator of transcription 3(STAT3) is an emerging target for cancer therapy. In this study, we identify Toosendanin (TSN) is an effective inhibitor of STAT3, leading to the impediment of various oncogenic processes… read more here.
Keywords: antitumor efficacy; promising antitumor; toosendanin demonstrates; efficacy osteosarcoma ... See more keywords